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Purpose.Toreportpatentforamenovale(PFO)asthecauseofretinalarteryocclusioninayoungandpreviouslyﬁtmaleanddiscuss
the appropriate medical and surgical management options. Methods. Interventional case report with serial fundus photographs of
an 18-year-old male presenting to the eye casualty with sudden onset left visual loss. Results. Visual acuities were 6/24 left and
6/4 right with a left aﬀerent pupillary defect. Slitlamp examination conﬁrmed a left hemiretinal artery occlusion and subsequent
cardiologyreviewwithtransoesophagealechocardiographyrevealedpatentforamenovalewhichwasclosedsurgically.Conclusions.
PFO is not uncommon and is often covert but predisposes individuals to embolic events. These events may be ophthalmic
with visual sequelae and so ophthalmologists, physicians, and other healthcare personnel should be aware of this important and
emerging association.
Copyright © 2009 Hiten G. Sheth et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Patent foramen ovale (PFO) represents a persistent congen-
ital interatrial communication of the heart, which failed to
close normally within the ﬁrst year of life, thus creating
the potential for a right-to-left shunt. The prevalence of
PFO is reported as 10–15% of the population by contrast
transthoracic echocardiography and 26% in autopsy studies.
Although generally not symptomatic, PFO predisposes the
individual to embolic events which may involve the eye.
2.CaseReport
An 18-year-old male presented to the eye casualty with a
history of left visual loss, which had occurred suddenly an
hour previously. He had no past ophthalmic history, gave
a past medical history of classical migraine (with visual
aura and headache), and had endured a long distance bus
journey the preceding day. There was no history of cigarette
smoking or illicit drug use. Visual acuities were 6/24 left
unaided not improving with pinhole and 6/4 unaided right.
Al e f ta ﬀerent pupillary defect (RAPD) was present, and loss
of left superior visual ﬁeld to confrontation with red pin
was demonstrated. Intraocular pressures were normal and
gonioscopyconﬁrmedopeniridocornealangles.Dilatedfun-
dal examination revealed a left inferior hemi-retinal artery
occlusion (Figure 1). Systemic neurological examination was
normal, and blood pressure was 115/68. Immediate treat-
ment included aspirin orally, acetazolomide intravenously,
ocular massage, and rebreathing into a paper bag.
At 3-day review, left visual acuity had improved to 6/6
with a still persistent RAPD. Full blood count, urea and
electrolytes, clotting, inﬂammatory markers, and throm-
bophilia screen were within normal range. He was reviewed
in cardiology, and right-to-left shunting across a patent
foramen ovale was revealed with transoesophageal echocar-
diography.Magneticresonanceimagingofthebrainrevealed
discrete abnormalities consistent with the previous localised
ischaemic events from emboli. He was treated with both
aspirin and clopidogrel and at 1-month review, visual acuity
remained good at 6/6, the retinal oedema had resolved and
a sclerosed branch retinal vessel was evident (Figure 2). He
subsequently underwent successful percutaneous closure of
the cardiac lesion and 1 year on from initial presentation he
remains free of visual or other neurological symptoms with
an acuity of 6/6.2 Journal of Ophthalmology
Figure 1: Colour photograph of left fundus at presentation, show-
ing acute left hemiretinal artery occlusion and associated retinal
oedema.
Figure 2: Colour photograph of left fundus 1 month after initial
artery occlusion showing marked resolution in signs and sclerosis
of vessel.
3. Discussion and Conclusion
Retinal artery occlusion in young patients is rare and only
a handful of other cases with PFO as the cause are reported
[1–4]. PFO is more common than perhaps appreciated by
themedicalprofession,withanaverageprevalenceatautopsy
of 26% [5]. Most patients with an incidental PFO and
no other systemic problems generally receive no treatment.
When associated with otherwise unexplained ophthalmic or
neurologic events, treatment may be medical (to include
aspirin, clopidogrel, or warfarin) or surgical (in the form
of a catheter-based procedure using Dacron patches or
percutaneous surgical closure with primary closure with
sutures). The potential complications of surgery must be
carefully balanced against the risk of recurrent cerebral or
ophthalmic embolic events. Interestingly, our patient had
suﬀered classical migraine attacks for 5 years prior to his
retinal artery occlusion, and there has been much recent
discussion implicating PFO in the aetiology of migraine
headache [6] and advocating surgical closure as a safe and
eﬀective treatment for migraine [7].
Ophthalmologists should thus consider PFO in patients
diagnosed with retinal artery occlusion, particularly younger
patients in whom no other aetiological risk factors can
be identiﬁed, and asking about a history of migraine
attacks may also be helpful in reaching the ﬁnal diagnosis.
PFO with ophthalmic and visual sequelae is an important
emerging association and prompt diagnosis and liaison with
cardiologists will help avoid unnecessary future ocular or
nonocular embolic events and associated morbidity.
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